Latest: FDA Approves New Biosimilar for Oncology Treatment

DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial

0 Mins
ARTICLE: DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial AUTHORS: Michael Fang, Dan Wang, Casey M Rebholz, Justin B Echouffo-Tcheugui 2 4, Olive Tang 5, Nae-Yuh Wang 1 2 6 7, Christine M Mitchell 1 2, Scott J Pilla 2 6 8, Lawrence J Appel 1 2 6, Elizabeth Selvin JOURNAL: Nat Med. 2025 Aug 5:10.1038/s41591-025-03823-3. doi: 10.1038/s41591-025-03823-3. Online ahead of print. Abstract The Dietary Approaches to Stop Hypertension (DASH) diet is rich in… Read More »DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial The post DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial first appeared on Medicine Matters.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago